Serum matrix metalloproteinase‐3 concentration is influenced by MMP‐3 −1612 5A/6A promoter genotype and associated with myocardial infarction
Open accessThe DOI matches its Crossref record.
Abstract
: Objectives. Matrix metalloproteinase‐3 (MMP‐3) is implicated in the formation of atherosclerotic plaques, and the MMP‐3 −1612 5A/6A polymorphism is associated with myocardial infarction (MI) and stable coronary artery disease (CAD). The present study examined whether the −1612 5A/6A polymorphism in the promoter region of the MMP‐3 gene influences serum concentrations of MMP‐3 and whether serum concentrations of MMP‐3 are related to extent of coronary atherosclerosis and risk of MI. Design and subjects. This case–control study was conducted in three hospitals in the northern part of Stockholm. A total of 755 MI patients aged below 60 were screened, 433 entered and 387 completed the study. Three hundred and eighty‐seven sex‐ and age‐matched control subjects were recruited from the general population of the same county. Methods. The MMP‐3 genotype was determined by Pyrosequencing TM and the serum MMP‐3 concentration was quantified with an immunoassay. Severity and extension of CAD was assessed by quantitative coronary angiography in a subgroup of patients (n = 243). Results. Patients had lower serum MMP‐3 concentration than controls. There was a strong association between MMP‐3 −1612 5A/6A genotype and serum concentrations of MMP‐3. The presence of one or two copies of the 6A‐allele was associated with a graded increase in serum MMP‐3. In female patients there was an inverse correlation (r = −0.39, P < 0.05) between serum MMP‐3 concentration and plaque area. Conclusion. In conclusion, the serum concentration of MMP‐3 is influenced by MMP‐3 −1612 5A/6A genotype and associated with MI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Clarke, R., Peden, J. F., Hopewell, J. C., Kyriakou, T., Goel, A., Heath, S. C., Parish, S., Barlera, S., Franzosi, M. G., Rust, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902604 · Cited by 1,671
Self-citationSpinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,120
The Coronary Artery Disease (C4D) Genetics Consortium (2011) · Nature Genetics · doi:10.1038/ng.782 · Cited by 674
“, Stockholm Heart Epidemiology Programme and Stockholm Coronary Artery Risk Factor study SHEEP/SCAR”
NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
Paramel Varghese, G., Folkersen, L., Strawbridge, R. J., Halvorsen, B., Yndestad, A., Ranheim, T., Krohg‐Sørensen, K., Skjelland, M., Espevik, T., Aukrust, P., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003031 · Cited by 306
Self-citationMatrix metalloproteinases in tumorigenesis: an evolving paradigm
Hua, H., Li, M., Luo, T., Yin, Y., & Jiang, Y. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0763-x · Cited by 300
Metadata
- Authors
- SAMNEGÅRD, A., SILVEIRA, A., LUNDMAN, P., BOQUIST, S., ODEBERG, J., HULTHE, J., MCPHEAT, W., TORNVALL, P., BERGSTRAND, L., ERICSSON, C. ‐., HAMSTEN, A., & ERIKSSON, P.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2005-09-26
- Volume
- 258
- Issue
- 5
- Pages
- 411-419
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2018775727
- Cited by
- 126
- References
- 0
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum matrix metalloproteinase‐3 concentration is influenced by MMP‐3 −1612 5A/6A promoter genotype and associated with myocardial infarction. https://app.cochat.ai/papers/10.1111/j.1365-2796.2005.01561.x
- The paper
- SAMNEGÅRD, A., SILVEIRA, A., LUNDMAN, P., BOQUIST, S., ODEBERG, J., HULTHE, J., MCPHEAT, W., TORNVALL, P., BERGSTRAND, L., ERICSSON, C. ‐., HAMSTEN, A., & ERIKSSON, P. (2005). Serum matrix metalloproteinase‐3 concentration is influenced by MMP‐3 −1612 5A/6A promoter genotype and associated with myocardial infarction. Journal of Internal Medicine. https://doi.org/10.1111/j.1365-2796.2005.01561.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.